Manhattan Psychology Group Joins ARC Health
ARC Health, a Thurston Group portfolio company, announces the acquisition of Manhattan Psychology Group, PC (MPG), a distinguished behavioral health practice with multiple locations catering to the Greater New York City Metro Area. Their physical offices are located on the Upper West Side…
MediBuddy and Aditya Birla Housing Finance Launch Exclusive Healthcare Plan for Housing Finance Customers
MediBuddy, India’s largest digital healthcare platform, and Aditya Birla Housing Finance Limited (ABHFL), a prominent player in the housing finance sector, have collaboratively introduced exclusive healthcare advantages for the customers of ABHFL. This strategic partnership aims to offer affordable and…
Bioforum Expands Clinical Trial Technology and Services with Acquisition of Validify
Bioforum, a data-focused, technology-driven CRO, today announced the acquisition of Validify (Applato Systems Ltd.), a leader in the automation of computer systems validation (CSV). With this expansion, Bioforum is addressing the growing demand for proven technology solutions to digitize and automate CSV,…
Halozyme Announces argenx Receives European Commission Approval of VYVGART® SC with ENHANZE® for Generalized Myasthenia Gravis
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that argenx received European Commission (EC) approval of VYVGART® SC (efgartigimod alfa and hyaluronidase-qvfc) co-formulated with ENHANZE® for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR)…
Spring Health announces dedicated mental health care experience for teens
Spring Health, the most comprehensive global mental health solution for employers and health plans, today announced the launch of a new dedicated teen experience. Spring Health for teens is the latest innovation in the Family Care suite of services, which offers…
U.S.-trained DOs gain global recognition
The International Association of Medical Regulatory Authorities (IAMRA) approved a resolution today to support the recognition of U.S.-trained DOs as fully licensed physicians equivalent to MDs in 47 IAMRA member countries during its 15th biennial Members General Assembly in Bali, Indonesia. The resolution was jointly submitted…
Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity
Biolexis Therapeutics, a clinical-stage AI-enabled drug discovery company, today announced the launch of Metabolexis, a new pipeline company developing three targeted oral small molecules for the treatment of Obesity and Type 2 Diabetes, with the potential to improve human Longevity….
TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML
TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for…
NUTEX HEALTH LAUNCHES INNOVATIVE PSYCHIATRIC SERVICES AT TEXAS HOSPITAL
Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that SE Texas ER & Hospital…
Akebia Therapeutics Resubmits New Drug Application to the FDA for Vadadustat
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for…
